{"id":167722,"date":"2023-07-17T22:22:38","date_gmt":"2023-07-18T03:22:38","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/07\/eli-lillys-experimental-alzheimers-drug-slows-progression-of-the-disease-study-finds"},"modified":"2023-07-17T22:22:38","modified_gmt":"2023-07-18T03:22:38","slug":"eli-lillys-experimental-alzheimers-drug-slows-progression-of-the-disease-study-finds","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/07\/eli-lillys-experimental-alzheimers-drug-slows-progression-of-the-disease-study-finds","title":{"rendered":"Eli Lilly\u2019s experimental Alzheimer\u2019s drug slows progression of the disease, study finds"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/eli-lillys-experimental-alzheimers-drug-slows-progression-of-the-disease-study-finds2.jpg\"><\/a><\/p>\n<p>There may soon be another option for an Alzheimer\u2019s drug capable of slowing the progression of the devastating disease.<\/p>\n<p>An experimental Alzheimer\u2019s drug from drugmaker Eli Lilly helped slow cognitive decline in patients in the early stages of the illness, according to the results of a late-stage clinical trial. Side effects of the drug, called donanemab, however, were serious in some cases, and included brain swelling and brain bleeds.<\/p>\n<p>Lilly representatives presented the results at the <a href=\"https:\/\/aaic.alz.org\/\">Alzheimer\u2019s Association International Conference<\/a> in Amsterdam on Monday. The research was published simultaneously in the Journal of the American Medical Association.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>There may soon be another option for an Alzheimer\u2019s drug capable of slowing the progression of the devastating disease. An experimental Alzheimer\u2019s drug from drugmaker Eli Lilly helped slow cognitive decline in patients in the early stages of the illness, according to the results of a late-stage clinical trial. Side effects of the drug, called [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-167722","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/167722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=167722"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/167722\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=167722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=167722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=167722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}